
1. immunotherapy. 2014;6(1):23-8. doi: 10.2217/imt.13.155.

partial recovery severe immune reconstitution inflammatory syndrome a
multiple sclerosis patient progressive multifocal leukoencephalopathy.

calvi a(1), de riz m, pietroboni am, ghezzi l, maltese v, arighi a, fumagalli gg,
jacini f, donelli c, comi g, galimberti d, scarpini e.

author information: 
(1)neurology unit, department pathophysiology & transplantation, 'dino
ferrari' center, university milan, fondazione c√† granda, irccs ospedale
maggiore policlinico, milan, italy.

progressive multifocal leukoencephalopathy (pml) rare severe
complication natalizumab therapy patients multiple sclerosis it
may accompanied immune reconstitution inflammatory syndrome (iris). here,
we describe case abnormally severe iris, occurred 2 months after
natalizumab-associated pml 38-year-old woman affected multiple sclerosis.
the patient john cunningham virus-positive treated 21 months when
she developed pml. subsequent iris diffusely afflicted brain, producing
edema signs intracranial hypertension, clinically severe form
compromising state consciousness, requiring intensive care high-dosage
steroid treatment. nevertheless, survived partially recovered. is
still difficulty differentiating pml progression iris onset 
not clear description literature different clinical forms iris,
prognostic factors guidelines properly treat complication order to
reduce residual disability patient surviving treatment
complication.

doi: 10.2217/imt.13.155 
pmid: 24341880  [indexed medline]

